We are live on ! Find out more
HI

Humankind Investments Portfolio holdings

AUM $175M
1-Year Est. Return 14.3%
This Fund
S&P 500
This Quarter Est. Return
+9.59%
1 Year Est. Return
+14.3%
3 Year Est. Return
+46.43%
5 Year Est. Return
+54.92%
10 Year Est. Return
AUM
$337M
AUM Growth
+$96.7M
Cap. Flow
+$69.8M
Cap. Flow %
20.69%
Top 10 Hldgs %
65.1%
Holding
137
New
22
Increased
54
Reduced
57
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 11.3%
2 Healthcare 11.2%
3 Consumer Staples 4.73%
4 Communication Services 3.09%
5 Materials 2.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTVA icon
26
Corteva
CTVA
$51.3B
$2.34M 0.69%
48,765
+2,738
+6% +$131K
PFE icon
27
Pfizer
PFE
$153B
$2.14M 0.63%
74,285
+13,406
+22% +$405K
MOS icon
28
The Mosaic Company
MOS
$7.33B
$2M 0.59%
56,105
+4,262
+8% +$151K
BG icon
29
Bunge Global
BG
$20.8B
$1.89M 0.56%
18,681
+774
+4% +$81.1K
VZ icon
30
Verizon
VZ
$196B
$1.79M 0.53%
47,508
-4,871
-9% -$172K
AMZN icon
31
Amazon
AMZN
$2.96T
$1.78M 0.53%
11,736
-1,121
-9% -$157K
BIL icon
32
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
$1.65M 0.49%
+18,000
New +$1.65M
WMT icon
33
Walmart Inc
WMT
$890B
$1.49M 0.44%
28,401
+99
+0.3% +$5.24K
UNH icon
34
UnitedHealth
UNH
$370B
$1.47M 0.44%
2,796
-234
-8% -$125K
FMC icon
35
FMC
FMC
$1.33B
$1.34M 0.4%
21,187
+8,382
+65% +$486K
HCA icon
36
HCA Healthcare
HCA
$89.5B
$1.33M 0.39%
4,908
+366
+8% +$90.5K
BMY icon
37
Bristol-Myers Squibb
BMY
$132B
$1.26M 0.38%
24,646
+4,403
+22% +$231K
AMGN icon
38
Amgen
AMGN
$222B
$1.16M 0.34%
4,027
-78
-2% -$21.3K
CF icon
39
CF Industries
CF
$17.3B
$1.11M 0.33%
13,946
+30
+0.2% +$2.39K
SYK icon
40
Stryker
SYK
$130B
$1.1M 0.32%
3,658
-164
-4% -$46K
BDX icon
41
Becton Dickinson
BDX
$48.2B
$1.08M 0.32%
4,409
+631
+17% +$156K
AWK icon
42
American Water Works
AWK
$26.9B
$1.07M 0.32%
8,078
+376
+5% +$47.4K
GEHC icon
43
GE HealthCare
GEHC
$32.4B
$1.02M 0.3%
13,137
-967
-7% -$67.7K
AGCO icon
44
AGCO
AGCO
$7.2B
$1.01M 0.3%
8,349
+76
+0.9% +$8.89K
XYL icon
45
Xylem
XYL
$28.1B
$1.01M 0.3%
8,818
-264
-3% -$26.3K
DHR icon
46
Danaher
DHR
$144B
$979K 0.29%
4,234
-253
-6% -$53.8K
PEP icon
47
PepsiCo
PEP
$190B
$978K 0.29%
5,757
+282
+5% +$46.8K
CMCSA icon
48
Comcast
CMCSA
$90B
$976K 0.29%
22,263
+1,475
+7% +$63.2K
TMO icon
49
Thermo Fisher Scientific
TMO
$220B
$968K 0.29%
1,824
+214
+13% +$104K
GILD icon
50
Gilead Sciences
GILD
$165B
$959K 0.28%
11,838
+31
+0.3% +$2.41K

Similar funds

Humankind Investments's Q4 2023 Portfolio in Review

As of Q4 2023, Humankind Investments held 137 positions worth $337M, up 40% from $240M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Humankind Investments deployed $69.8M of net new capital in Q4 2023, opening 22 new positions and adding to 54 existing holdings. Its largest new stake was Vanguard Total World Stock ETF: 101,000 shares worth $10.4M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Staples.

On the sell side, the largest reduction was Microsoft, an estimated $842K trimmed.

  • Humankind Investments's largest Q4 2023 buy was Vanguard Total World Stock ETF: 101,000 shares worth $10.4M.
  • Humankind Investments added most to Invesco QQQ Trust in Q4 2023, an estimated $13.6M increase.
  • Humankind Investments's biggest Q4 2023 reduction was Microsoft, cutting an estimated $842K.
  • Humankind Investments fully exited Sony in Q4 2023, selling an estimated $3.33M.
  • Humankind Investments's ten largest holdings make up 65% of its $337M portfolio in Q4 2023.
  • Humankind Investments opened 22 new positions and closed 2 in Q4 2023.
  • Humankind Investments's portfolio value rose 40% quarter-over-quarter to $337M.

Based on Humankind Investments's 13F filing for Q4 2023, filed 14 Feb 2024.